Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Zinc can be a helpful secondary treatment for certain skin conditions, but more research is needed to guide its use.

Chitosan-coated dutasteride nanocapsules improve hair treatment, and physical stimulation boosts effectiveness.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

Erosive pustular dermatosis of the scalp is a type of skin inflammation often confused with other conditions, requiring continuous treatment.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Hair transplants can effectively treat hair loss from CCCA in African American women if there's no inflammation.

Platelet-rich plasma (PRP) is a safe and potentially effective way to treat hair loss, especially when combined with minoxidil.

Ethosomes improve drug delivery through the skin but may have side effects like irritation.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Latanoprost may cause scalp inflammation and delayed healing.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Propionibacterium acnes might be linked to hair casts and possibly alopecia.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Tailor treatments for vitiligo to patient needs for best results.

High-potency steroids or tacrolimus are effective treatments for Erosive Pustular Dermatosis of the Scalp.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Personalized treatment plans are important for people with alopecia areata.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

Hydroxychloroquine may help treat alopecia areata in children.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.